Wilson Sonsini Goodrich & Rosati is pleased to sponsor LaunchBio’s Larger Than Life Science Series: Discovery and Development, Bringing a Gene Therapy to Market. Cell and gene therapy related research and development in the US continues to grow at a fast rate, with the FDA signaling its interest in moving these products to clinical development. While the promise of breakthrough treatments is tantalizing, researchers and pharma companies in the US are still in the early stages of getting these new therapies reviewed, approved and available to patients who need them.
Lori Doyle
ldoyle@wsgr.comBased in the SOMA and San Diego offices, Mike Hostetler provides strategic IP counseling to growth enterprises in the pharmaceutical and biotechnology, and information technology industries.